Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZSCAN4D Inhibitors

ZSCAN4D inhibitors refer to a chemical class that specifically targets and modulates the activity of the ZSCAN4D gene. ZSCAN4D is a member of the zinc finger and SCAN domain-containing (ZSCAN) family of proteins, which are involved in the regulation of gene expression through interactions with DNA. The protein encoded by the ZSCAN4D gene contains a zinc finger domain, a structural motif that enables the protein to bind directly to DNA, allowing it to function as a transcription factor. ZSCAN4D plays a crucial role in chromatin remodeling, genomic stability, and telomere maintenance, particularly in cells that exhibit high rates of division and DNA replication, such as embryonic stem cells. By binding to specific sequences within DNA, ZSCAN4D can influence the expression of genes involved in maintaining genome integrity and facilitating telomere elongation.

Inhibitors of ZSCAN4D act by interfering with the normal function of this transcription factor, potentially disrupting its ability to bind DNA or altering its regulatory effects on chromatin. This class of inhibitors could act through several mechanisms, such as allosteric modulation, competitive binding, or direct interaction with the zinc finger domain, preventing proper DNA binding. Inhibition of ZSCAN4D can lead to alterations in chromatin structure, gene expression, and genomic stability, as the disruption of ZSCAN4D function may impact the processes that this protein normally regulates, such as telomere lengthening and chromatin organization. Such inhibitors are of significant interest in understanding the fundamental molecular biology of cells that rely on rapid division and genomic maintenance, providing insights into the intricate dynamics of transcription factor regulation and chromatin architecture.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

I-BET 151 Hydrochloride

1300031-49-5 (non HCl Salt)sc-391115
10 mg
$450.00
2
(0)

I-BET151, a bromodomain and extraterminal (BET) protein inhibitor, may inhibit ZNF644 expression by interfering with the binding of BET proteins to acetylated histones, affecting gene transcription.

EPZ6438

1403254-99-8sc-507456
1 mg
$66.00
(0)

EPZ-6438, a histone methyltransferase EZH2 inhibitor, may impact ZNF644 expression by modulating the methylation status of histones, thereby affecting gene transcription.

GSK J1

1373422-53-7sc-391113
sc-391113A
10 mg
50 mg
$193.00
$813.00
(0)

GSK-J1, a histone demethylase inhibitor, may inhibit ZNF644 expression by modulating the demethylation status of histones, thereby affecting gene transcription.

PFI 3

1819363-80-8sc-507340
10 mg
$300.00
(0)

PFI-3, a protein interaction inhibitor, may inhibit ZNF644 expression by interfering with the binding of specific protein partners, thereby impacting gene transcription.

UNC1999

1431612-23-5sc-475314
5 mg
$142.00
1
(0)

UNC1999, a histone methyltransferase inhibitor, may inhibit ZNF644 expression by modulating the methylation status of histones, thereby affecting gene transcription.

GSK126

1346574-57-9sc-490133
sc-490133A
sc-490133B
1 mg
5 mg
10 mg
$92.00
$243.00
$306.00
(0)

GSK-LSD1, a lysine-specific histone demethylase 1 (LSD1) inhibitor, may impact ZNF644 expression by modulating the demethylation status of histones, affecting gene transcription.